The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
The Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review
Open accessAbstract
The Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog) was developed in the 1980s to assess the level of cognitive dysfunction in Alzheimer’s disease. Advancements in the research field have shifted focus toward pre-dementia populations, and use of the ADAS-Cog has extended into these pre-dementia studies despite concerns about its ability to detect important changes at these milder stages of disease progression. If the ADAS-Cog cannot detect important changes, our understanding of pre-dementia disease progression may be compromised and trials may incorrectly conclude that a novel treatment approach is not beneficial. The purpose of this review was to assess the performance of the ADAS-Cog in pre-dementia populations, and to review all modifications that have been made to the ADAS-Cog to improve its measurement performance in dementia or pre-dementia populations. The contents of this review are based on bibliographic searches of electronic databases to locate all studies using the ADAS-Cog in pre-dementia samples or subsamples, and to locate all modified versions. Citations from relevant articles were also consulted. Overall, our results suggest the original ADAS-Cog is not an optimal outcome measure for pre-dementia studies; however, given the prominence of the ADAS-Cog, care must be taken when considering the use of alternative outcome measures. Thirty-one modified versions of the ADAS-Cog were found. Modification approaches that appear most beneficial include altering scoring methodology or adding tests of memory, executive function, and/or daily functioning. Although modifications improve the performance of the ADAS-Cog, this is at the cost of introducing heterogeneity that may limit between-study comparison.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
Alzheimer's Disease Neuroimaging Initiative (ADNI)
Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cb3e25 · Cited by 2,572
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Mild cognitive impairment: a concept in evolution
Petersen, R. C., Caracciolo, B., Brayne, C., Gauthier, S., Jelic, V., & Fratiglioni, L. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12190 · Cited by 1,694
Grundman, M. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.59 · Cited by 972
Aging, Memory, and Mild Cognitive Impairment
Petersen, R. C., Kokmen, E., Waring, S. C., Smith, G. E., Ivnik, R. J., & Tangelos, E. G. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004717 · Cited by 888
Amyloid deposition, hypometabolism, and longitudinal cognitive decline
Landau, S. M., Mintun, M. A., Joshi, A. D., Koeppe, R. A., Petersen, R. C., Aisen, P. S., Weiner, M. W., Jagust, W. J., & Initiative, F. T. A. D. N. (2012) · Annals of Neurology · doi:10.1002/ana.23650 · Cited by 727
Mohs, R. C., Knopman, D., Petersen, R. C., Ferris, S. H., Ernesto, C., Grundman, M., Sano, M., Bieliauskas, L., Geldmacher, D., Clark, C., et al. (1997) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199700112-00003 · Cited by 692
Plassman, B. L., Williams, J. W., Burke, J. R., Holsinger, T., & Benjamin, S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-3-201008030-00258 · Cited by 681
Initiative, F. T. A. D. N., Crane, P. K., Carle, A., Gibbons, L. E., Insel, P., Mackin, R. S., Gross, A., Jones, R. N., Mukherjee, S., Curtis, S. M., et al. (2012) · Brain Imaging and Behavior · doi:10.1007/s11682-012-9186-z · Cited by 621
Frequency and course of mild cognitive impairment in a multiethnic community
Manly, J. J., Tang, M., Schupf, N., Stern, Y., Vonsattel, J. G., & Mayeux, R. (2008) · Annals of Neurology · doi:10.1002/ana.21326 · Cited by 589
Cooper, C., Sommerlad, A., Lyketsos, C. G., & Livingston, G. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14070878 · Cited by 570
Mohs, R. C., Knopman, D. S., Petersen, R. C., Ferris, S. H., Ernesto, C., Grundman, M., Sano, M., Bieliauskas, L. A., Geldmacher, D., Clark, C., et al. (1997) · PubMed · Cited by 487
Reijnders, J., van Heugten, C., & van Boxtel, M. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.07.003 · Cited by 444
Fiatarone Singh, M. A., Gates, N., Saigal, N., Wilson, G. C., Meiklejohn, J., Brodaty, H., Wen, W., Singh, N., Baune, B. T., Suo, C., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.09.010 · Cited by 424
Chiu, C.-C., Su, K.-P., Cheng, T.-C., Liu, H.-C., Chang, C.-J., Dewey, M. E., Stewart, R., & Huang, S.-Y. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.05.015 · Cited by 406
A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment
on behalf of the Rofecoxib Protocol 078 study group, Thal, L. J., Ferris, S. H., Kirby, L., Block, G. A., Lines, C. R., Yuen, E., Assaid, C., Nessly, M. L., Norman, B. A., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300690 · Cited by 402
Neuropsychiatric Manifestations in Mild Cognitive Impairment: A Systematic Review of the Literature
Apostolova, L. G., & Cummings, J. L. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000112509 · Cited by 391
Suzuki, T., Shimada, H., Makizako, H., Doi, T., Yoshida, D., Ito, K., Shimokata, H., Washimi, Y., Endo, H., & Kato, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061483 · Cited by 384
Montero-Odasso, M. M., Sarquis-Adamson, Y., Speechley, M., Borrie, M. J., Hachinski, V. C., Wells, J., Riccio, P. M., Schapira, M., Sejdic, E., Camicioli, R. M., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0643 · Cited by 381
Self-citationSnitz, B. E. (2009) · JAMA · doi:10.1001/jama.2009.1913 · Cited by 336
Luchsinger, J. A., Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., & Bagiella, E. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150493 · Cited by 285
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease
Portelius, E., Zetterberg, H., Skillbäck, T., Törnqvist, U., Andreasson, U., Trojanowski, J. Q., Weiner, M. W., Shaw, L. M., & Mattsson, N. (2015) · Brain · doi:10.1093/brain/awv267 · Cited by 279
Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues
Perneczky, R., Pohl, C., Sorg, C., Hartmann, J., Komossa, K., Alexopoulos, P., Wagenpfeil, S., & Kurz, A. (2006) · Age and Ageing · doi:10.1093/ageing/afj054 · Cited by 276
Mild Cognitive Impairment: A Systematic Review
Mariani, E., Monastero, R., & Mecocci, P. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-12104 · Cited by 246
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study
Doraiswamy, P. M., Sperling, R. A., Coleman, R. E., Johnson, K. A., Reiman, E. M., Davis, M. D., Grundman, M., Sabbagh, M. N., Sadowsky, C. H., Fleisher, A. S., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182661f74 · Cited by 226
Tricco, A. C., Soobiah, C., Berliner, S., Ho, J. M., Ng, C. H., Ashoor, H. M., Chen, M. H., Hemmelgarn, B., & Straus, S. E. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.130451 · Cited by 209
Impact of APOE in mild cognitive impairment
Farlow, M. R., He, Y., Tekin, S., Xu, J., Lane, R., & Charles, H. C. (2004) · Neurology · doi:10.1212/01.wnl.0000144279.21502.b7 · Cited by 198
Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study
AV45-A11 Study Group, Doraiswamy, P. M., Sperling, R. A., Johnson, K., Reiman, E. M., Wong, T. Z., Sabbagh, M. N., Sadowsky, C. H., Fleisher, A. S., Carpenter, A., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.9 · Cited by 195
Longitudinal Change of Biomarkers in Cognitive Decline
Lo, R. Y. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.123 · Cited by 189
Schneider, L. S., Insel, P. S., & Weiner, M. W. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.343 · Cited by 169
Possible therapeutic value of melatonin in mild cognitive impairment: A retrospective study
Furio, A. M., Brusco, L. I., & Cardinali, D. P. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00491.x · Cited by 167
Buschert, V. C., Friese, U., Teipel, S. J., Schneider, P., Merensky, W., Rujescu, D., Möller, H., Hampel, H. J., & Büerger, K. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-100999 · Cited by 163
ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
Wang, J., Logovinsky, V., Hendrix, S. B., Stanworth, S. H., Perdomo, C., Xu, L., Dhadda, S., Do, I., Rabe, M., Luthman, J., et al. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-312383 · Cited by 160
Initiative, F. T. A. D. N., Skinner, J., Carvalho, J. O., Potter, G. G., Thames, A., Zelinski, E., Crane, P. K., & Gibbons, L. E. (2012) · Brain Imaging and Behavior · doi:10.1007/s11682-012-9166-3 · Cited by 151
Motor function and incident dementia: a systematic review and meta-analysis
Kueper, J. K., Speechley, M. R., Lingum, N. R., & Montero‐Odasso, M. (2017) · Age and Ageing · doi:10.1093/ageing/afx084 · Cited by 149
Self-citationHua, X., Lee, S., Yanovsky, I., Leow, A. D., Chou, Y.-Y., Ho, A. J., Gutman, B., Toga, A. W., Jack, C. R., Bernstein, M. A., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.07.011 · Cited by 145
Lin, C., Chen, P.-K., Chang, Y., Chuo, L.-J., Chen, Y.-S., Tsai, G. E., & Lane, H. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.08.010 · Cited by 143
Bettermann, K., Arnold, A. M., Williamson, J. D., Rapp, S. R., Sink, K. M., Toole, J. F., Carlson, M. C., Yaşar, S., DeKosky, S. T., & Burke, G. L. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2010.11.002 · Cited by 135
Sensitivity to change and prediction of global change for the Alzheimer’s Questionnaire
Malek‐Ahmadi, M. H., Chen, K., Davis, K. J., Belden, C. M., Powell, J. J., Jacobson, S. A., & Sabbagh, M. N. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0092-z · Cited by 133
Herholz, K., Westwood, S., Haense, C., & Dunn, G. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.090902 · Cited by 132
Volume changes in Alzheimer’s disease and mild cognitive impairment: cognitive associations
Initiative, A. T. A. D. N., Evans, M. C., Barnes, J., Nielsen, C. F., Kim, L. G., Clegg, S., Blair, M., Leung, K. K., Douiri, A., Boyes, R. G., et al. (2009) · European Radiology · doi:10.1007/s00330-009-1581-5 · Cited by 131
Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI
Landau, S. M., Horng, A., Fero, A., Jagust, W. J., Initiative, A. D. N., Initiative, A. D. N., Weiner, M. W., Aisen, P., Weiner, M. W., Aisen, P., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002576 · Cited by 130
Therapeutic application of melatonin in mild cognitive impairment.
Cardinali, D. P., Vigo, D. E., Olivar, N., Vidal, M. F., Furio, A. M., & Brusco, L. I. (2012) · Europe PMC (PubMed Central) · Cited by 117
Podhorná, J., Krahnke, T., Shear, M. A., Harrison, J., & Initiative, A. D. N. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0170-5 · Cited by 115
Body Mass Index and Cognitive Decline in Mild Cognitive Impairment
Cronk, B. B., Johnson, D. K., & Burns, J. M. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181a6bf3f · Cited by 113
Loewenstein, D., Curiel, R. E., Greig, M. T., Bauer, R. M., Rosado, M., Bowers, D., Wicklund, M. R., Crocco, E., Pontecorvo, M. J., Joshi, A. D., et al. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.02.056 · Cited by 105
Raghavan, N., Samtani, M. N., Farnum, M., Yang, E., Novak, G., Grundman, M., Narayan, V., DiBernardo, A., & Initiative, A. D. N. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.05.2187 · Cited by 96
Rozzini, L., Chilovi, B. V., Bertoletti, E., Conti, M., Rio, I. D., Trabucchi, M., & Padovani, A. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1523 · Cited by 93
Graham, D. P., Cully, J. A., Snow, A. L., Massman, P. J., & Doody, R. S. (2004) · PubMed · Cited by 92
Reuter, I., Mehnert, S., Sammer, G., Oechsner, M., & Engelhardt, M. (2012) · Journal of Aging Research · doi:10.1155/2012/235765 · Cited by 91
Association of fish oil supplement use with preservation of brain volume and cognitive function
Daiello, L. A., Gongvatana, A., Dunsiger, S., Cohen, R. A., Ott, B. R., & Initiative, A. D. N. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.02.005 · Cited by 89
Administration and Scoring Variance on the ADAS-Cog
Connor, D. J., & Sabbagh, M. N. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15312 · Cited by 89
Ho, A. J., Hua, X., Lee, S., Leow, A., Yanovsky, I., Gutman, B. A., Dinov, I. D., Leporé, N., Stein, J. L., Toga, A. W., et al. (2009) · Human Brain Mapping · doi:10.1002/hbm.20882 · Cited by 87
Plasma Urate and Progression of Mild Cognitive Impairment
Irizarry, M. C., Raman, R., Schwarzschild, M. A., Becerra, L. M., Thomas, R. G., Peterson, R. C., Ascherio, A., & Aisen, P. S. S. (2008) · Neurodegenerative Diseases · doi:10.1159/000170883 · Cited by 86
Wessels, A. M., Siemers, E. R., Yu, P., Andersen, S. W., Holdridge, K. C., Sims, J. R., Sundell, K., Stern, Y., Rentz, D. M., Dubois, B., et al. (2015) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2015.82 · Cited by 86
Initiative, T. A. D. N., Ueckert, S., Plan, E. L., Ito, K., Karlsson, M. O., Corrigan, B., & Hooker, A. C. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1315-5 · Cited by 81
Ferris, S. H. (2003) · International Psychogeriatrics · doi:10.1017/s1041610203009220 · Cited by 80
(ADNI), T. A. D. N. I., Bouallègue, F. B., Mariano‐Goulart, D., & Payoux, P. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0260-z · Cited by 80
Whitehair, D. C., Sherzai, A., Emond, J. A., Raman, R., Aisen, P. S. S., Petersen, R. C., Fleisher, A., & Study, A. D. C. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.12.003 · Cited by 73
Derivation of a New ADAS-cog Composite Using Tree-based Multivariate Analysis
Llano, D. A., Laforet, G. A., & Devanarayan, V. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181f5b8d8 · Cited by 73
Verma, N., Beretvas, S. N., Pascual, B., Masdeu, J. C., Markey, M. K., & Initiative, T. A. D. N. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0151-0 · Cited by 70
Kile, S. J., Au, W. J., Parise, C. A., Rose, K., Donnel, T., Hankins, A. I., Chan, M., & Ghassemi, A. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311486 · Cited by 68
Inoue, M., Jimbo, D., Taniguchi, M., & Urakami, K. (2011) · Psychogeriatrics · doi:10.1111/j.1479-8301.2010.00345.x · Cited by 61
Sano, M., Raman, R., Emond, J. A., Thomas, R. G., Petersen, R. C., Schneider, L. S., & Aisen, P. S. S. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181f883b7 · Cited by 61
McGough, E. L., Cochrane, B. B., Pike, K. C., Logsdon, R. G., McCurry, S. M., & Teri, L. L. (2013) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2013.02.005 · Cited by 60
Long-Term Observation of a Multicomponent Cognitive Intervention in Mild Cognitive Impairment
Buschert, V. C., Giegling, I., Teipel, S. J., Jolk, S., Hampel, H. J., Rujescu, D., & Büerger, K. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07270 · Cited by 59
Grill, J. D., Di, L., Lu, P. H., Lee, C., Ringman, J., Apostolova, L. G., Chow, N., Kohannim, O., Cummings, J. L., Thompson, P. M., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.006 · Cited by 58
Förster, S., Buschert, V. C., Teipel, S. J., Friese, U., Buchholz, H.-G., Drzezga, A., Hampel, H., Bartenstein, P., & Buerger, K. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-0025 · Cited by 54
Zanotta, D., Puricelli, S., & Bonoldi, G. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s51092 · Cited by 54
Ye, B. S., Lee, W., Ham, J. H., Lee, J. J., Lee, P. H., Sohn, Y. H., & Initiative, T. A. D. N. (2016) · European Journal of Neurology · doi:10.1111/ene.12969 · Cited by 52
Moon, B., Kim, S., Park, Y. H., Lim, J., Youn, Y. C., Kim, S., Jang, J., & Initiative, A. D. N. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170225 · Cited by 50
Beaumont, L. D., Study, T. A. D. C., Pelleïeux, S., Lamarre-Théroux, L., Dea, D., & Poirier, J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160373 · Cited by 48
Crocco, E., Loewenstein, D., Curiel, R. E., Alperin, N. J., Czaja, S. J., Harvey, P. D., Sun, X., Lenchus, J. D., Raffo, A., Peñate, A., et al. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.08.015 · Cited by 48
Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer’s Disease
Matías‐Guiu, J. A., Cabrera‐Martín, M. N., Curiel, R. E., Valles‐Salgado, M., Rognoni, T., Moreno‐Ramos, T., Carreras, J. L., Loewenstein, D., & Matías‐Guiu, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170604 · Cited by 47
Balsis, S. M., Unger, A. A., Benge, J. F., Geraci, L. D., & Doody, R. S. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.2409 · Cited by 45
Biomarkers for Predicting Cognitive Decline in those with Normal Cognition
Steenland, K., Initiative, A. D. N., Zhao, L., Goldstein, F. C., Cellar, J. S., & Lah, J. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-2014-131343 · Cited by 44
Kennedy, R., Cutter, G., & Schneider, L. S. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.03.003 · Cited by 43
Gonzales, M. M., Insel, P. S., Nelson, C. J., Tosun, D., Mattsson, N., Mueller, S. G., Sacuiu, S. F., Bickford, D. D., Weiner, M. W., & Mackin, R. S. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.04.011 · Cited by 40
Mackin, R. S., Insel, P. S., Tosun, D., Mueller, S. G., Schuff, N. W., Truran‐Sacrey, D., Raptentsetsang, S. T., Lee, J., Jack, C. R., Aisen, P. S. S., et al. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.021 · Cited by 38
Suicide in Two Patients with a Diagnosis of Probable Alzheimer Disease
Ferris, S. H., Hofeldt, G. T., Carbone, G., Masciandaro, P., Troetel, W. M., & Imbimbo, B. P. (1999) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199904000-00005 · Cited by 37
Porto, F. H. D. G., Coutinho, A. M., Pinto, A. L. D. S., Gualano, B., Duran, F., Prando, S., Ono, C. R., Spíndola, L., de Oliveira, M. O., do Vale, P. H. F., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150033 · Cited by 35
The TE4D-Cog: a new test for detecting early dementia in English-speaking populations
Mahoney, R., Johnston, K., Katona, C., Maxmin, K., & Livingston, G. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1412 · Cited by 34
Revising the ADAS-cog for a More Accurate Assessment of Cognitive Impairment
Wouters, H., van Gool, W. A., Schmand, B. A., & Lindeboom, R. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318174f8b9 · Cited by 34
Förster, S., Buschert, V. C., Buchholz, H., Teipel, S. J., Friese, U., Zach, C., la Fougère, C., Rominger, A., Drzezga, A. E., Hampel, H. J., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-100996 · Cited by 33
Toledo, J. B., Korff, A., Shaw, L. M. J., Trojanowski, J. Q., Zhang, J., & Initiative, T. A. D. N. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt266 · Cited by 33
Aging, Physical Activity, and Disease Prevention 2012
Reuter, I. (2012) · Journal of Aging Research · doi:10.1155/2012/373294 · Cited by 32
Examining the reliability of ADAS-Cog change scores
Grochowalski, J. H., Liu, Y., & Siedlecki, K. L. (2015) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2015.1127320 · Cited by 31
Zhang, N., Initiative, A. D. N., Song, X., Zhang, Y., Chen, W., D’Arcy, R. C. N., Darvesh, S., Fisk, J. D., & Rockwood, K. J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0048 · Cited by 30
Pyo, G., Elble, R. J., Ala, T. A., & Markwell, S. J. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000201846.22213.76 · Cited by 28
Miao, Y. (2012) · Journal of Chinese Integrative Medicine · doi:10.3736/jcim20120407 · Cited by 26
Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment
Rozzini, L., Chilovi, B. V., Bertoletti, E., Conti, M. Z., Delrio, I., Trabucchi, M., & Padovani, A. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207006163 · Cited by 25
Development of a straightforward and sensitive scale for MCI and early AD clinical trials
Huang, Y., Ito, K., Billing, C. B., Anziano, R., & Initiative, A. D. N. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.03.008 · Cited by 23
Ihl, R., Ferris, S. H., Robert, P. H., Winblad, B. G., Gauthier, S. G., & Tennigkeit, F. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2679 · Cited by 23
Does Adaptive Cognitive Testing Combine Efficiency with Precision? Prospective Findings
Wouters, H., van Campen, J., Appels, B. A., Lindeboom, R., Buiter, M., de Haan, R. J., Zwinderman, A. H., van Gool, W. A., & Schmand, B. A. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101743 · Cited by 20
Ferris, S. H. (1999) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199912001-00019 · Cited by 16
Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI
Caroli, A., Prestia, A., Wade, S., Chen, K., Ayutyanont, N., Landau, S. M., Madison, C. M., Haense, C., Herholz, K., Reiman, E. M., et al. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000071 · Cited by 15
Initiative, T. A. N., Torosyan, N., Mason, K., Dahlbom, M. L., & Silverman, D. H. S. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3634-3 · Cited by 15
Pakdaman, H., Harandi, A. A., Abbasi, M., Kasmaei, H. D., Ashrafi, F., Gharagozli, K., Assarzadegan, F., Behnam, B., & Ahmadi, M. A. (2017) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000458521 · Cited by 14
O'Halloran, J. P., Kemp, A. S., Salmon, D. P., Tariot, P. N., & Schneider, L. S. (2011) · Current Alzheimer Research · doi:10.2174/156720511795563692 · Cited by 13
COGNITIVE/CLINICAL ENDPOINTS FOR PRE-DEMENTIA AD TRIALS
Aisen, P. S. S. (2015) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2015.62 · Cited by 13
Biomarker Positive and Negative Subjects in the ADNI Cohort: Clinical Characterization
Publisher, B. S. (2012) · Current Alzheimer Research · doi:10.2174/156720512804142976 · Cited by 11
Lowe, D. A., Balsis, S. M., Benge, J. F., & Doody, R. S. (2015) · Psychological Assessment · doi:10.1037/pas0000133 · Cited by 10
Dubois, B., Zaïm, M., Touchon, J., Vellas, B. J., Robert, P. H., Murphy, M. F., Pujadas, F., Rainer, M. K., Soininen, H. S., Riordan, H., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111370 · Cited by 10
Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials
Kennedy, R., Cutter, G., Wang, G., & Schneider, L. S. S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150847 · Cited by 10
Summary measures were a useful alternative for analyzing therapeutic clinical trial data
Carusone, S. C., Goldsmith, C. H., Smieja, M., & Loeb, M. B. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.05.009 · Cited by 6
Research works printed but not linked: 11
- Graham DP, 2004, Alzheimer Dis Assoc Disord, 18, 236
- Aisen PS, 2015, J Prev Alzheimers Dis, 2, 82
- 10.1017/S1355617711001755 · DOI
- 10.1037/pas0000163 · doi:10.1037/pas0000163
- 10.1097/00002093-199206020-00004 · doi:10.1097/00002093-199206020-00004
- Cardinali DP, 2012, Am J Neurodegener Dis, 1, 280
- Bruno M, 2017, Cerebrovascular Disease, Stroke and Cognitive Dysfunction Abstracts, e5
- Gu C, 2017, Int J Clin Exp Med, 10, 3554
- Wouters H, 2008, J Alzheimers Dis, 22, 236
- Wessels A, 2015, J Prev Alzheimers Dis, 2, 227
- Montero-Odasso MM, 2017, JAMA Neurol, 54, S154
Cited by
Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
Kim, C. K., Lee, Y. R., Ong, L., Gold, M., Kalali, A., & Sarkar, J. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215699 · Cited by 241
Guo, J., Wang, Z., Liu, R., Huang, Y., Zhang, N., & Zhang, R. (2020) · Brain and Behavior · doi:10.1002/brb3.1831 · Cited by 165
Nazir, S., Jankowski, V., Bender, G., Zewinger, S., Rye, K.-A., & van der Vorst, E. P. C. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.006 · Cited by 140
Detect and correct bias in multi-site neuroimaging datasets
Wachinger, C., Rieckmann, A., & Pölsterl, S. (2021) · Medical Image Analysis · doi:10.1016/j.media.2020.101879 · Cited by 115
Lansdall, C. J., McDougall, F., Butler, L. M., Delmar, P., Pross, N., Qin, S., McLeod, L., Zhou, X., Kerchner, G. A., & Doody, R. S. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2022.102 · Cited by 99
Metadata
- Authors
- Kueper, J. K., Speechley, M., & Montero-Odasso, M.
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2018-04-24
- Volume
- 63
- Issue
- 2
- Pages
- 423-444
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2797937217
- Cited by
- 424
- References
- 108
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.